There are 3 papers on HLA-DRB5 in aging research: 2 observational studies in people, 1 review.
- Humans2
Associations
1Appendicular lean mass
downin silico1
1 study
Appendicular lean mass
downin silico1
HLA-DRB5 is associated with appendicular lean mass in silico.
“HLA-DRB5, HLA-DRB1, and AGER were identified as potential therapeutic targets for ALM decline by drug target MR and further confirmed by SMR analysis.”
In silico
International immunopharmacology
Latest
1 paper in 12 monthsInternational Journal of Molecular Sciences
Greenspace Exposure and DNA Methylation Age Acceleration: A Systematic Review and Molecular Pathway Analysis
Systematic reviewPopulations
International Immunopharmacology
Sarcopenia and immune-mediated inflammatory diseases: Evaluating causality and exploring therapeutic targets for sarcopenia through Mendelian randomization
Mendelian randomization in peopleImmune response
Age
Gene-based aggregate SNP associations between candidate AD genes and cognitive decline
Genetic association study in peopleMechanisms